IRCT201506222480N6已完成3 期
The effect of genistein supplementation on glycemic state, insulin resistance and adipose tissue in non alcoholic fatty liver patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Volunteers whom their fatty liver were confirmed by ultrasonography; Don't have any Acute or chronic disease of the liver or bile ducts
- •Exclusion criteria: Severe weight loss or gain; Pregnancy; ALT serum level 10 times more than normal range.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
The effect of genistein supplementation on metabolic parameters and oxidative stress in postmenopausal women with type 2 diabetes.type 2 diabetes.Non-insulin-dependent type 2 diabetesIRCT201611033664N18Vice-chancellor for research, Tabriz Nutrition Research Center, Tabriz University of Medical Science60
已完成
2 期
Effect of genistein supplementation on serum level of homocystein and PAI-1 (Plasminogen Activator Inhibitor-1) in postmenopausal women with type-2 diabetes mellitus.Type 2 diabetes mellitus.Type 2 diabetes mellitusIRCT20100408003664N23utritional Reseach Center of Tabriz University of Medical Sciences60
已完成
不适用
Effect of Genestein as food supplement in patients with Sanfilippo syndrome.Sanfilippo syndrome (MPS III) comprises 4 closely related inborn errors of lysosomal degradation of the glycosaminoglycan heparan sulphate (GAGs). Accumulation of heparan sulfate, results in progressive and severe mental deterioration, which is the clinical hallmark of MPS III. Patients with MPS III usually die before the 3th decade. At present there is no causal therapy for patients with MPS III and treatment is symptomatic.NL-OMON21882AMC Amsterdam30
已完成
3 期
Treatment of non-alcoholic fatty liver diseaseon alcoholic fatty liver.Fatty (change of) liver, not elsewhere classifiedIRCT201312132480N5Shiraz University Of Medical Sciences100
已完成
不适用
Efficacy of genestein as food supplement in patients with the Sanfilippo syndrome (an extension study).Sanfilippo syndrome (MPS III)NL-OMON22208Academic Medical Center Amsterdam (AMC)28